IQV vs STRO · P/E 23, rev $15.40B vs rev $62.0M
IQVIA Holdings Inc (IQV) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the IQV and STRO stock pages for the full models.
Not investment advice.